Understand the source comparison
Best Peptides for Tennis Injury: Research-Grade Comparison
BPC-157 VEGF upregulation, angiogenesis, nitric oxide modulation Tendinopathy (tennis elbow, Achilles, rotator cuff) 200–500 mcg/day Twice daily (subcutaneous near injury site) Preclinical rodent studies; human case reports Strongest evidence for tendon-to-bon
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- VEGF upregulation, angiogenesis, nitric oxide modulation
- Tendinopathy (tennis elbow, Achilles, rotator cuff)
- 200–500 mcg/day
- Twice daily (subcutaneous near injury site)
- Preclinical rodent studies; human case reports
- Strongest evidence for tendon-to-bone healing; clinical trials in humans lacking
- TB-500
- Actin upregulation, fibroblast migration, cytokine modulation
- Muscle strains, ligament injuries, chronic tendinopathy
- 2–2.5 mg loading (twice weekly × 2 weeks), then 2 mg weekly
- Twice weekly loading, then weekly maintenance
- Veterinary studies in horses; human anecdotal reports
- Effective for soft tissue migration; dosing extrapolated from animal models
- GHK-Cu
- Copper-dependent antioxidant activity, MMP modulation, collagen synthesis
- Oxidative stress reduction, ECM remodeling in tendons
- 1–3 mg per injection
- 3–4 times weekly
- In vitro fibroblast studies; limited human trials
- Protects repair tissue from ROS damage; best as adjunct to BPC-157/TB-500
- Ipamorelin + CJC-1295
- Growth hormone secretagogue, IGF-1 upregulation
- Systemic recovery support (not injury-specific)
- 200–300 mcg each per injection
- Once daily (evening)
- Human GH secretion studies; no injury-specific trials
- Supports systemic recovery; not a substitute for targeted peptides